Controversies and advances in the management of Wilms' tumour

Archives of Disease in Childhood

Volumn 87, Issue 3, 2002, Pages 241-244

  Pritchard Jones, K ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DOXORUBICIN; VINCRISTINE;

CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; GENETIC PREDISPOSITION; HERITABILITY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LONG TERM CARE; NEPHRECTOMY; NEPHROBLASTOMA; PEDIATRIC SURGERY; PENETRANCE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CHILD; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; KIDNEY NEOPLASMS; MUTATION; RISK ASSESSMENT; WILMS TUMOR; WT1 PROTEINS;

EID: 0036724002     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.87.3.241     Document Type: Review

References (28)

1. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumour: A report from the NWTSG
2. Comparison between single dose and divided dose administration of dactinomycin and doxorubicin for patients with Wilms' tumour: A report from the NWTSG
3. Optimal duration of preoperative therapy in unilaterol and nonmetastatic Wilms' tumor in children older than 6 months: Results of the Ninth International Society of Pediatric Oncology Wilms' Tumour Trial and Study
4. The role of biopsy in the diagnosis of renal tumours of childhood: Results of the UKCCSG Wilms' tumour study 3
5. The treatment of Wilms' tumour: Results of the UKCCSG second Wilms' tumour study
6. The genetics of Wilms' tumor; a case of disrupted development
7. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogential development in Denys-Drash syndrome
8. Frasier syndrome, part of the Denys Drash continuum or simply a WT1 gene associated disorder of intersex and nephropathy?
9. Spectrum of early onset nephrotic syndrome associated with missense mutations
10. Increased tumour risk for BWS patients correlates with abherrant H19 and not KCNQ1OT1 methylation: Occurrence of KCNQ10T1 hypomethylation in familial cases of BWS
11. Nephromegaly in infancy and early childhood: A risk factor for Wilms' tumor in Beckwith-Wiedmann syndrome
12. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: Identification of loss-of-function mutations in the GPC3 gene
13. Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q211
14. Evidence for susceptibility genes to familial Wilms' tumor in addition to WT1, FWT1 and FWT2
15. Penetrance of mutations in the familial Wilms' tumour gene, WT1
16. Constitutional WT1 mutations in Wilms' tumor patients
17. Correlation of germ-line mutations and two-hit inactivation WT1 gene with Wilms' tumors of stromal-predominant histology
18. Molecular genetic pathways to Wilms' tumour
19. Nephrogenic rests and the pathogenesis of Wilms' tumour: Developmental and clinical considerations
20. Does nephroblastomatosis influence the natural history and relapse rate in Wilms' tumour? A single centre experience over 11 years
21. A FISH approach to defining the extent and possible clinical significance of deletions at the WAGR locus
22. Screening of children with hemihypertrophy, aniridia, and Beckwith-Wiedemann syndrome in patients with Wilms' tumor: A report from the National Wilms' Tumor Study
23. Screening for Wilms' tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy
24. Isolated hemihyperplasia (hemihypertropy): Report of a prospective multicenter study of the incidence of neoplasia and review
25. Children at increased risk for Wilms' tumor monitoring issues
26. Factor affecting the risk of contralateral Wilms' tumor development: A report from the National Wilms' Tumor Study Group
27. Renal failure in the Denys-Drash and Wilms' tumor-aniridia syndromes
28. Surgery related factors and local recurrence of Wilms' tumor in National Wilms' tumour study 4